138 related articles for article (PubMed ID: 38293996)
41. Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort.
Zanatta E; Cocconcelli E; Castelli G; Giraudo C; Fraia AS; De Zorzi E; Gatto M; Ienna L; Treppo E; Malandrino D; Cereser L; Emmi G; Giannelli F; Bellani S; Martini A; Moccaldi B; Ghirardello A; Avouac J; Quartuccio L; Allanore Y; Doria A; Spagnolo P; Balestro E; Iaccarino L
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37541742
[TBL] [Abstract][Full Text] [Related]
42. Predictors of rapidly progressive interstitial lung disease and prognosis in Chinese patients with anti-melanoma differentiation-associated gene 5-positive dermatomyositis.
Li M; Zhao X; Liu B; Zhao Y; Li X; Ma Z; Yang Q
Front Immunol; 2023; 14():1209282. PubMed ID: 37691917
[TBL] [Abstract][Full Text] [Related]
43. Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies.
Sun F; Zhao J; Li Y; Wang H; Cao X; Cheng W; Chen J
Int Immunopharmacol; 2023 Feb; 115():109609. PubMed ID: 36577160
[TBL] [Abstract][Full Text] [Related]
44. Immune cell profiles of idiopathic inflammatory myopathy patients expressed anti-aminoacyl tRNA synthetase or anti-melanoma differentiation-associated gene 5 autoantibodies.
Lan JL; Chang SH; Tsay GJ; Chen DY; Chao YH; Li JP
BMC Immunol; 2023 Sep; 24(1):33. PubMed ID: 37752437
[TBL] [Abstract][Full Text] [Related]
45. Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Liu Y; Wang G; Wang H; Zhao X; Chen D; Su X; Yan J; Liang J; Lin J; Zhao K
Clin Rheumatol; 2022 Jul; 41(7):2103-2112. PubMed ID: 35305186
[TBL] [Abstract][Full Text] [Related]
46. Dynamic change in red cell distribution width as a predictor for short-time mortality in dermatomyositis-associated rapid progressive interstitial lung disease.
Chen F; Jin Q; Zhang Y; Wang G; Li G; Shu X
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38580342
[TBL] [Abstract][Full Text] [Related]
47. Lung transplantation for interstitial lung disease in idiopathic inflammatory myositis: A cohort study.
Rivière A; Picard C; Berastegui C; Mora VM; Bunel V; Godinas L; Salvaterra E; Rossetti V; Savale L; Israel-Biet D; Demant X; Bermudez J; Meloni F; Jaksch P; Magnusson J; Beaumont L; Perch M; Mornex JF; Knoop C; Aubert JD; Hervier B; Nunes H; Humbert M; Gottlieb J; Uzunhan Y; Le Pavec J
Am J Transplant; 2022 Dec; 22(12):2990-3001. PubMed ID: 35988032
[TBL] [Abstract][Full Text] [Related]
48. Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis.
Xing X; Li A; Li C
Respir Med; 2020 Oct; 172():106134. PubMed ID: 32905890
[TBL] [Abstract][Full Text] [Related]
49. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
[TBL] [Abstract][Full Text] [Related]
50. Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review.
Liu Y; Liu X; Xie M; Chen Z; He J; Wang Z; Dai J; Cai H
Respir Med; 2020; 165():105920. PubMed ID: 32174452
[TBL] [Abstract][Full Text] [Related]
51. Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease.
Xu A; Ye Y; Fu Q; Lian X; Chen S; Guo Q; Lu LJ; Dai M; Lv X; Bao C
Rheumatology (Oxford); 2021 Jul; 60(7):3343-3351. PubMed ID: 33331866
[TBL] [Abstract][Full Text] [Related]
52. Comparison of pulmonary and small airways function between idiopathic inflammatory myopathies patients with and without interstitial lung disease.
Panagopoulos PK; Georgakopoulou VE; Pezoulas VC; Malagari K; Fotiadis DI; Goules AV; Vassilakopoulos T; Tzioufas AG
Clin Exp Rheumatol; 2024 Feb; 42(2):337-343. PubMed ID: 37382448
[TBL] [Abstract][Full Text] [Related]
53. Association of anti-nuclear matrix protein 2 antibody with complications in patients with idiopathic inflammatory myopathies: A meta-analysis of 20 cohorts.
Zhong L; Yu Z; Song H
Clin Immunol; 2019 Jan; 198():11-18. PubMed ID: 30445156
[TBL] [Abstract][Full Text] [Related]
54. Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.
Sclafani A; D'Silva KM; Little BP; Miloslavsky EM; Locascio JJ; Sharma A; Montesi SB
Respir Res; 2019 Nov; 20(1):256. PubMed ID: 31718649
[TBL] [Abstract][Full Text] [Related]
55. Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Tian M; Huang W; Ren F; Luo L; Zhou J; Huang D; Tang L
Clin Rheumatol; 2020 Feb; 39(2):575-583. PubMed ID: 31758424
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases.
Jin YZ; Xie MS; Yang C; Wu RL; Zhou YB; Li XM
Scand J Rheumatol; 2021 May; 50(3):218-226. PubMed ID: 33475038
[No Abstract] [Full Text] [Related]
57. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
Fujisawa T; Hozumi H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
J Rheumatol; 2019 Aug; 46(8):935-942. PubMed ID: 31092718
[TBL] [Abstract][Full Text] [Related]
58. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies.
Mecoli CA; Christopher-Stine L
Curr Rheumatol Rep; 2018 Apr; 20(5):27. PubMed ID: 29637383
[TBL] [Abstract][Full Text] [Related]
59. Clinical and prognostic features associated with anti-Ro52 autoantibodies in connective tissue diseases patients with interstitial lung disease.
Shi X; Pu X; Cao D; Yan T; Ye Q
Clin Exp Rheumatol; 2023 Nov; 41(11):2257-2263. PubMed ID: 37279146
[TBL] [Abstract][Full Text] [Related]
60. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
Chen N; Diao CY; Gao J; Zhao DB
Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
